Pronađeno: 1-6 / 6 radova

Autori: Romiti Giulio Francesco

>> Prikaži sve rezultate

>> Sve godine

Naslov Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients (Article)
Autori Boriani Giuseppe Bonini Niccolo Vitolo Marco Mei Davide Antonio Imberti Jacopo Francesco Gerra Luigi Romiti Giulio Francesco Corica Bernadette Proietti Marco Diemberger Igor Dan Gheorghe-Andrei Potpara Tatjana S  Lip Gregory YH 
Info EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2024), vol. 119 br. , str. 53-63
Projekat European Union [899871]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients (Article)
Autori Vitolo Marco Proietti Marco Imberti Jacopo F Bonini Niccolo Romiti Giulio Francesco Mei Davide A Malavasi Vincenzo Livio Diemberger Igor Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S  Dan Gheorghe-Andrei Lip Gregory YH Boriani Giuseppe 
Info JOURNAL OF CLINICAL MEDICINE, (2023), vol. 12 br. 3, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry (Article)
Autori Ding Wern Yew Proietti Marco Romiti Giulio Francesco Vitolo Marco Fawzy Ameenathul Mazaya Boriani Giuseppe Marin Francisco Blomstrom-Lundqvist Carina Potpara Tatjana S  Fauchier Laurent Lip Gregory YH 
Info EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2023), vol. 107 br. , str. 60-65
Projekat Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Servier; Edwards; Vifor; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati:
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (Article)
Autori Romiti Giulio Francesco Proietti Marco Vitolo Marco Bonini Niccolo Fawzy Ameenathul Mazaya Ding Wern Yew Fauchier Laurent Marin Francisco Nabauer Michael Dan Gheorghe Andrei Potpara Tatjana S  Boriani Giuseppe Lip Gregory YH 
Info BMC MEDICINE, (2022), vol. 20 br. 1, str. -
Projekat Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Epidemiology and impact of frailty in patients with atrial fibrillation in Europe (Article)
Autori Proietti Marco Romiti Giulio Francesco Vitolo Marco Harrison Stephanie L Lane Deirdre A Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S  Dan Gheorghe-Andrei Maggioni Aldo P Cesari Matteo Boriani Giuseppe Lip Gregory YH 
Info AGE AND AGEING, (2022), vol. 51 br. 8, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry (Article)
Autori Proietti Marco Romiti Giulio Francesco Vitolo Marco Potpara Tatjana S  Boriani Giuseppe Lip Gregory YH 
Info EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, (2022), vol. 8 br. 7, str. 778-786
Projekat Abbott Vascular International; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; The Alliance Daiichi S
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX